We curate a digest of the latest news in our field for advocates, policymakers, community coalitions and all who work toward shaping policies and practices to effectively prevent substance use and treat addiction.
Young man holding and vaping an electronic cigarette, e-cig, ecigarette.
Johnson & Johnson announced it has reached a $20.4 million settlement with two Ohio counties ahead of a huge federal trial to determine responsibility for the opioid crisis, The Washington Post reports.
A judge ruled Wednesday that a Philadelphia group’s plan to run a supervised drug injection site does not violate federal drug laws, The New York Times reports.
The Centers for Disease Control and Prevention says the number of vaping-related injuries continues to increase, and has surpassed the previously reported estimate of 530, The Wall Street Journal reports.
The proposed settlement with OxyContin maker Purdue Pharma is “no more than a stopgap for local and state governments,” which will continue to face costs related to the opioid crisis that far exceed the agreed upon amounts, according to a new report by Moody’s Investors Services.
A new survey finds the rate of nicotine vaping among 8th graders in the United States almost doubled in the past year. The rate among 12th graders rose 22%, according to Reuters.
The Centers for Disease Control and Prevention announced this week it has activated its Emergency Operations Center to increase support for the investigation into hundreds of cases of severe lung illnesses associated with vaping.
Some e-cigarette companies are considering challenging a federal government plan to ban the sale of most flavored e-cigarettes, according to The New York Times.
President Trump on Wednesday announced he has directed the Food and Drug Administration to ban the sale of most flavored e-cigarettes, The New York Times reports.
OxyContin maker Purdue Pharma has reached a tentative settlement worth billions of dollars to resolve thousands of lawsuits brought by state and local governments who sued the drug company for its role in the opioid epidemic.
Justice Department lawyers argued in federal court last week against the planned opening of the nation’s first supervised injection site in Philadelphia, NPR reports.
Medication used to treat opioid addiction can be helpful for teens who misuse opioids, a new study suggests. Until now, the evidence for the effectiveness of medication-assisted treatment in teens has been unclear, HealthDay reports.
The Centers for Disease Control and Prevention is investigating at least 215 possible cases of severe lung disease associated with vaping. Teens and young adults should not use e-cigarette products, the agency said.
Some states are objecting to a proposed deal with OxyContin maker Purdue Pharma to resolve more than 2,000 lawsuits over the company’s role in the opioid crisis, The Wall Street Journal reports.
Opioid-related deaths decreased 5%, while fentanyl deaths rose 11% from the second half of 2017 to the first half of 2018, according to a new report by the Centers for Disease Control and Prevention.
A change proposed by the Department of Health and Human Services that would give doctors greater access to addiction treatment records is raising patient privacy concerns, PBS NewsHour reports.
Companies that make fruity and candy-flavored pods compatible with Juul devices are seeing big increases in sales, after Juul Labs stopped selling most of its flavored nicotine pods under pressure from the Food and Drug Administration, The New York Times reports.
This website uses cookies. We use cookies and similar technologies to give
you the best experience. By using this website, you accept our Privacy Policy and Terms of Use.
Get Support
